“COST-EFFECTIVENESS ANALYSIS OF AVELUMAB TREATMENT FOR PATIENTS WITH METASTATIC MERKEL CELL CARCINOMA” (2020) Voprosy onkologii, 66(2), pp. 109–119. doi:10.37469/0507-3758-2020-66-2-109-119.